ACORN THERAPY LIMITED
Opportunity 80/100 (exceptional), bankability 75/100. Strong seller-intent signal (83/100, director aged 69). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2024-07-31 | 2023-07-31 |
|---|---|---|
| Total assets | — | £1.8k |
| Current assets | — | £18.4k |
| Cash | — | £1.8k |
| Debtors | — | £16.6k |
| Net assets | — | £-2.0k |
| Average employees | 100 | — |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Corporate timeline (17 events)Click to expand
- 2025-04-30📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-04-22📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-04-24📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-04-13📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-04-26📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-01-17📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-04-25📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-04-09📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2017-04-27📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2016-04-12📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2015-08-14📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2015-04-26📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2014-07-29📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2014-04-28📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2013-07-25📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2009-07-15🏢Company incorporatedAs ACORN THERAPY LIMITED
- 2009-07-15➕KNIPE, Daphne Helen appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Long-tenure founder: Senior director has been in place 17 years — deep operational knowledge concentrated in one person.
- +Founder age: Director aged approximately 69 — succession pressure is live.
- +No director turnover: Company is 17 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.
- primaryFounder aged 63+: Senior director is approximately 69. Approaching typical UK retirement age — succession thinking likely.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- secondary12+ year tenure: Director in role 17 years.
- secondaryStable-but-static management: Company is 17 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mrs Daphne Helen Knipe Individual · British · DOB 07/1957 · age 69 | 75–100% | — | 75-100% shares | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · LA postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 1ST FOR CARE (GB) LTD→ 08725925 · est 2013 · no financials extracted | — | — | — | — | 12y | — | — |
| 3A DENTAL CARE LTD→ 06447094 · est 2007 · no financials extracted | — | — | — | — | 18y | — | — |
| A BREATH FOR LIFE CHILDRENS CHARITY→ 03518921 · est 1998 · no financials extracted | — | — | — | — | 28y | — | — |
| A FAMILY'S BEST FRIEND LTD→ 13215381 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| A R MEDICS LIMITED→ 06741340 · est 2008 · no financials extracted | — | — | — | — | 17y | — | — |
| ABBEYFIELD LANCASTER SOCIETY LIMITED(THE)→ 00737334 · est 1962 · no financials extracted | — | — | — | — | 63y | — | — |
| ABBEYFIELD SILVERDALE SOCIETY→ 10845391 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| ACA REPORTING LIMITED→ 12130250 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| ACCESS 4 U CIC→ 15823514 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ACROSS THE BAY LTD→ 11947347 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| ACS HEALTH LIMITED→ 14043891 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| ADVANCED CARE & MANAGEMENT LTD→ 15708140 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.